MR Imaging Detection of CNS Lesions in Tuberous Sclerosis Complex: The Usefulness of T1WI with Chemical Shift Selective Images

References

1. 1.↵
   1. Fryer AE,
   2. Chalmers A,
   3. Connor JM, et al

   . Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987;1:659–61 doi:10.1016/S0140-6736(87)90416-8 pmid:2882085

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Kandt RS,
   2. Haines JL,
   3. Smith M, et al

   . Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37–41 doi:10.1038/ng0992-37 pmid:1303246

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Tee AR,
   2. Fingar DC,
   3. Manning BD, et al

   . Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A 2002;99:13571–76 doi:10.1073/pnas.202476899 pmid:12271141

   Abstract/FREE Full Text
4. 4.↵
   1. Gao X,
   2. Zhang Y,
   3. Arrazola P, et al

   . TSC tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 2002;4:699–704 doi:10.1038/ncb847 pmid:12172555

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Inoki K,
   2. Li Y,
   3. Zhu T, et al

   . TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002;4:648–57 doi:10.1038/ncb839 pmid:12172553

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Roach ES,
   2. Sparagana SP

   . Diagnosis of tuberous sclerosis complex. J Child Neurol 2004;19:643–49 doi:10.1177/08830738040190090301 pmid:15563009

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Ridler K,
   2. Bullmore ET,
   3. De Vries PJ, et al

   . Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol Med 2001;31:1437–46 doi:10.1017/s0033291701004561 pmid:11722158

   CrossRefPubMedWeb of Science
8. 8.↵
   1. DiMario FJ Jr.

   Brain abnormalities in tuberous sclerosis complex. J Child Neurol 2004;19:650–57 doi:10.1177/08830738040190090401 pmid:15563010

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Kalantari BN,
   2. Salamon N

   . Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging. AJR Am J Roentgenol 2008;190:W304–09 doi:10.2214/AJR.07.2928 pmid:18430816

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Jeong MG,
    2. Chung TS,
    3. Coe CJ, et al

    . Application of magnetization transfer imaging for intracranial lesions of tuberous sclerosis. J Comput Assist Tomogr 1997;21:8–14 doi:10.1097/00004728-199701000-00002 pmid:9022761

    CrossRefPubMed
11. 11.↵
    1. Girard N,
    2. Zimmerman RA,
    3. Schnur RE, et al

    . Magnetization transfer in the investigation of patients with tuberous sclerosis. Neuroradiology 1997;39:523–28 doi:10.1007/s002340050459 pmid:9258933

    CrossRefPubMed
12. 12.↵
    1. Pinto Gama HP,
    2. da Rocha AJ,
    3. Braga FT, et al

    . Comparative analysis of MR sequences to detect structural brain lesions in tuberous sclerosis. Pediatr Radiol 2006;36:119–25 doi:10.1007/s00247-005-0033-x pmid:16283285

    CrossRefPubMed
13. 13.↵
    1. Kadom N,
    2. Trofimova A,
    3. Vezina GL

    . Utility of magnetization transfer T1 imaging in children with seizures. AJNR Am J Neuroradiol 2013;34:895–98 doi:10.3174/ajnr.A3396 pmid:23153867

    Abstract/FREE Full Text
14. 14.↵
    1. Baldassari S,
    2. Ribierre T,
    3. Marsan E, et al

    . Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol 2019;138:885–900 doi:10.1007/s00401-019-02061-5 pmid:31444548

    CrossRefPubMed
15. 15.↵
    1. Becker AJ,
    2. Urbach H,
    3. Scheffler B, et al

    . Focal cortical dysplasia of Taylor’s balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29–37 doi:10.1002/ana.10251 pmid:12112044

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Barkovich AJ,
    2. Kuzniecky RI,
    3. Jackson GD, et al

    . A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873–87 doi:10.1212/01.wnl.0000183747.05269.2d pmid:16192428

    Abstract/FREE Full Text
17. 17.↵
    1. Holmes GL,
    2. Stafstrom CE

    ; Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 2007;48:617–30 doi:10.1111/j.1528-1167.2007.01035.x pmid:17386056

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kimura Y,
    2. Shioya A,
    3. Saito Y, et al

    . Radiologic and pathologic features of the transmantle sign in focal cortical dysplasia: the T1 signal is useful for differentiating subtypes. AJNR Am J Neuroradiol 2019;40:1060–66 doi:10.3174/ajnr.A6067 pmid:31097427

    Abstract/FREE Full Text
19. 19.↵
    1. Kusama M,
    2. Sato N,
    3. Tanei Z-I, et al

    . Enhanced MR conspicuity of type IIb focal cortical dysplasia by T1WI with CHESS. Neurol Clin Pract 2021;11:e750–52 doi:10.1212/CPJ.0000000000000987 pmid:34840898

    Abstract/FREE Full Text
20. 20.↵
    1. Kusama M,
    2. Sato N,
    3. Kimura Y, et al

    . Quick MR neuromelanin imaging using a chemical shift selective pulse. Magn Reson Med Sci 2021;20:106–11 doi:10.2463/mrms.tn.2019-0167 pmid:32074593

    CrossRefPubMed
21. 21.↵
    1. Northrup H,
    2. Krueger DA

    ; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49:243–54 doi:10.1016/j.pediatrneurol.2013.08.001 pmid:24053982

    CrossRefPubMed
22. 22.↵
    1. van Eeghen AM,
    2. Terán LO,
    3. Johnson J, et al

    . The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines. Neuroradiology 2013;55:1007–14 doi:10.1007/s00234-013-1184-3 pmid:23644537

    CrossRefPubMed
23. 23.↵
    1. Gallagher A,
    2. Grant EP,
    3. Madan N, et al

    . MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex. J Neurol 2010;257:1373–81 doi:10.1007/s00415-010-5535-2 pmid:20352250

    CrossRefPubMed
24. 24.↵
    1. Daily DK,
    2. Ardinger HH,
    3. Holmes GE

    . Identification and evaluation of mental retardation. Am Fam Physician 2000;61:1059–67 pmid:10706158

    PubMedWeb of Science
25. 25.↵
    1. Wolff SD,
    2. Balaban RS

    . Magnetization transfer imaging: practical aspects and clinical applications. Radiology 1994;192:593–99 doi:10.1148/radiology.192.3.8058919 pmid:8058919

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Shin W,
    2. Gu H,
    3. Yang Y

    . Incidental magnetization transfer contrast by fat saturation preparation pulses in multislice Look-Locker echo planar imaging. Magn Reson Med 2009;62:520–26 doi:10.1002/mrm.22034 pmid:19526506

    CrossRefPubMed
27. 27.↵
    1. Richardson EP Jr

    . Pathology of tuberous sclerosis: neuropathologic aspects. Ann N Y Acad Sci 1991;615:128–39 pmid:2039138

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Jansen FE,
    2. Braun KP,
    3. van Nieuwenhuizen O, et al

    . Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol 2003;60:1580–84 doi:10.1001/archneur.60.11.1580 pmid:14623730

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Goodman M,
    2. Lamm SH,
    3. Engel A, et al

    . Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 1997;12:85–90 doi:10.1177/088307389701200203 pmid:9075016

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Okanishi T,
    2. Fujimoto A,
    3. Kanai S, et al

    . Association between diffuse cerebral MRI lesions and the occurrence and intractableness of West syndrome in tuberous sclerosis complex. Epilepsy Behav 2020;103:106535 doi:10.1016/j.yebeh.2019.106535 pmid:31645317

    CrossRefPubMed
31. 31.↵
    1. Peters JM,
    2. Struyven RR,
    3. Prohl AK, et al

    . White matter mean diffusivity correlates with myelination in tuberous sclerosis complex. Ann Clin Transl Neurol 2019;6:1178–90 doi:10.1002/acn3.793 pmid:31353853

    CrossRefPubMed
32. 32.↵
    1. Tsai JD,
    2. Ho MC,
    3. Lee HY, et al

    . Disrupted white matter connectivity and organization of brain structural connectomes in tuberous sclerosis complex patients with neuropsychiatric disorders using diffusion tensor imaging. Magma 2021;34:189–200 doi:10.1007/s10334-020-00870-4 pmid:32715372

    CrossRefPubMed
33. 33.↵
    1. Taoka T,
    2. Aida N,
    3. Fujii Y, et al

    . White matter microstructural changes in tuberous sclerosis: evaluation by neurite orientation dispersion and density imaging (NODDI) and diffusion tensor images. Sci Rep 2020;10:436 doi:10.1038/s41598-019-57306-w pmid:31949187

    CrossRefPubMed